powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023371515
Wanxing Chai-Ho
M.D.
Hematology-Oncology
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 050112
Hospital
CCN 050262
Hospital
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
816
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
31
Brand share
34.9%
Top prescribed drugs
Acyclovir
83 claims
Levofloxacin
63 claims
Ruxolitinib Phosphate
56 claims
Levothyroxine Sodium
53 claims
Posaconazole
44 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
10
By payment type
Consulting Fee
$2K
Food and Beverage
$414
Top paying entities
Consulting Fee
$2K
Food and Beverage
$414
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,116
Unique beneficiaries
—
Total services
12,528
Distinct HCPCS
29
Medicare payment
$560K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — top quintile (cohort median 4,173).
